Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | +0.64% | -1.27% | -15.22% |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
05-08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.22% | 177M | |
-16.99% | 8.67B | |
+67.79% | 4.25B | |
-1.10% | 2.51B | |
-9.46% | 2.47B | |
-44.11% | 2.25B | |
-8.47% | 1.91B | |
-19.29% | 1.56B | |
-41.75% | 1.19B | |
+11.31% | 1.15B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix : Morgan Stanley Adjusts Price Target on Biodesix to $25 From $20, Maintains Overweight Rating